3

OWNERSHIP DOCUMENT

Company: Phathom Pharmaceuticals, Inc.
Filed: November 4, 2019
Period of Report: October 25, 2019
Accession Number: 0001104659-19-059558

View Document ↗ View on SEC.gov ↗